Premium
Ultrasonographically guided vacuum‐assisted excision for multiple breast masses: Non‐randomized comparison with conventional open excision
Author(s) -
Wang Wei Jun,
Wang Qiang,
Cai Qing Ping,
Zhang Jian Quan
Publication year - 2009
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.21394
Subject(s) - medicine , cosmesis , surgery , surgical excision , randomized controlled trial , complication , radiology , fibroadenoma , breast cancer , cancer
Background This study aimed to evaluate the safety, efficacy, and patient acceptance of ultrasonographically guided vacuum‐assisted excision (UGVAE) for multiple breast masses. Methods Ninty‐eight patients with low‐risk multiple breast masses were non‐randomized to either UGVAE or conventional open excision (COE). Clinical data were prospectively collected and analyzed. Results The two groups were similar with age, side predilection, size and number of lesions. Forty‐seven patients had UGVAE with 8‐gauge probe and 15 patients with 11‐gauge probe. All lesions were removed through same incision. Patients both in UGVAE and COE had complete removal of all imaged evidence of the masses by ultrasonography on initial follow‐up. The majority of excised lesions were fibroadenomas and fibrocystic changes. The overall complication rate was 8.1% in UGVAE group and 5.6% in COE group. Patients treated with UGVAE were more highly satisfied with the cosmetic aspects as compared patients with COE. The postprocedure incomplete removal rate was slightly higher in UGVAE than in COE with 12‐month follow‐up, but the overall difference was not statistically significant. Conclusion Both seem to be equally safe and effective, but UGVAE has certain advantages, that include minimal residual scar, excellent cosmesis outstanding, offering an useful alternative to the excision of low‐risk multiple benign masses. J. Surg. Oncol. 2009;100:675–680. © 2009 Wiley‐Liss, Inc.